Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)

​ Conditions: Thyroid Eye Disease, TED; Graves Orbitopathy

Interventions: Drug: linsitinib; Drug: Placebo

Sponsors: Sling Therapeutics, Inc.

Recruiting Conditions: Thyroid Eye Disease, TED; Graves Orbitopathy
Interventions: Drug: linsitinib; Drug: Placebo
Sponsors: Sling Therapeutics, Inc.
Recruiting